BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 2348149)

  • 41. Pap test--with or without vaginal smear?
    Milicić-Juhas V; Perić M; Pajtler M; Prvulović I; Curzik D
    Coll Antropol; 2010 Mar; 34(1):69-74. PubMed ID: 20437636
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The pap-smear history of women with invasive cervical squamous carcinoma. A case-control study from Sweden.
    Andersson-Ellström A; Seidal T; Grannas M; Hagmar B
    Acta Obstet Gynecol Scand; 2000 Mar; 79(3):221-6. PubMed ID: 10716304
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Improving the effectiveness of cervical cancer screening.
    Ellman R; Chamberlain J
    J R Coll Gen Pract; 1984 Oct; 34(267):537-42. PubMed ID: 6492026
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The effectiveness of cervical screening: a population-based case-control study.
    van der Graaf Y; Zielhuis GA; Peer PG; Vooijs PG
    J Clin Epidemiol; 1988; 41(1):21-6. PubMed ID: 3335869
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Screening History Among Women with Invasive Cervical Cancer in an Academic Medical Center: Will We Miss Cancers Following Updated Guidelines?
    Nitschmann C; May T; Mirkovic J; Feldman S
    J Womens Health (Larchmt); 2016 Aug; 25(8):826-31. PubMed ID: 26859535
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Cervical cancer screening: women's knowledge, attitudes and preferences.
    Nicoll PM; Narayan KV; Paterson JG
    Health Bull (Edinb); 1991 May; 49(3):184-90. PubMed ID: 1917453
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Screening for cervical cancer: U.S. Preventive Services Task Force recommendation statement.
    Moyer VA;
    Ann Intern Med; 2012 Jun; 156(12):880-91, W312. PubMed ID: 22711081
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Review of negative and low-grade cervical smears in women with invasive cervical cancer after the first 3 years of the national cervical screening programme in Slovenia.
    Repše-Fokter A; Pogačnik A; Snoj V; Primic-Žakelj M; Fležar MS
    Cytopathology; 2012 Feb; 23(1):23-9. PubMed ID: 20964743
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Self-collection of vaginal specimens for human papillomavirus testing in cervical cancer prevention (MARCH): a community-based randomised controlled trial.
    Lazcano-Ponce E; Lorincz AT; Cruz-Valdez A; Salmerón J; Uribe P; Velasco-Mondragón E; Nevarez PH; Acosta RD; Hernández-Avila M
    Lancet; 2011 Nov; 378(9806):1868-73. PubMed ID: 22051739
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Cervical cytology in the Vale of Trent faculty of the Royal College of General Practitioners, 1985-8.
    Wilson A
    BMJ; 1990 Feb; 300(6721):376-8. PubMed ID: 2106993
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The fallacy of the screening interval for cervical smears.
    Boyce JG; Fruchter RG; Romanzi L; Sillman FH; Maiman M
    Obstet Gynecol; 1990 Oct; 76(4):627-32. PubMed ID: 2216192
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Cervical cancer in women with comprehensive health care access: attributable factors in the screening process.
    Leyden WA; Manos MM; Geiger AM; Weinmann S; Mouchawar J; Bischoff K; Yood MU; Gilbert J; Taplin SH
    J Natl Cancer Inst; 2005 May; 97(9):675-83. PubMed ID: 15870438
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Non-participation in screening: the case of cervical cancer in Denmark.
    Dugué PA; Lynge E; Bjerregaard B; Rebolj M
    Prev Med; 2012; 54(3-4):266-9. PubMed ID: 22300964
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Cervical screening in general practice: call and recall.
    Ridsdale LL
    J R Coll Gen Pract; 1987 Jun; 37(299):257-9. PubMed ID: 3129556
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The pattern of presentation of carcinoma of the uterine cervix in East Anglia 1960 to 1975.
    de Bono AM; Pillers EM; Kirk NM
    Br J Obstet Gynaecol; 1978 Dec; 85(12):887-92. PubMed ID: 737154
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Progress in the early detection of cervix cancer from the viewpoint of the Saarland cancer register].
    Brenner H; Wiebelt H; Ziegler H
    Geburtshilfe Frauenheilkd; 1990 Apr; 50(4):304-9. PubMed ID: 2358181
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Factors affecting uptake of cervical and breast cancer screening among perimenopausal women in Hong Kong.
    Chan C; Ho SC; Chan SG; Yip YB; Wong FC; Cheng F
    Hong Kong Med J; 2002 Oct; 8(5):334-41. PubMed ID: 12376710
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Pap smear screening, pap smear abnormalities and psychosocial risk factors among women in a residential alcohol and drug rehabilitation facility.
    Soccio J; Brown M; Comino E; Friesen E
    J Adv Nurs; 2015 Dec; 71(12):2858-66. PubMed ID: 26279461
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [National results of cervix cytology diagnosis in 1992; efficacy of screening could be improved].
    Giard RW; Hermans J; Doornewaard H
    Ned Tijdschr Geneeskd; 1994 Jun; 138(26):1325-30. PubMed ID: 8028678
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Attendance rate in the Polish Cervical Cancer Screening Program in the years 2007-2009].
    Spaczyński M; Karowicz-Bilinska A; Rokita W; Molińska-Glura M; Januszek-Michalecka L; Seroczyński P; Uchlik J; Nowak-Markwitz E
    Ginekol Pol; 2010 Sep; 81(9):655-63. PubMed ID: 20973201
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.